Melinta Therapeutics reports that the FDA has cleared three antimicrobial susceptibility tests that will be available to guide physicians towards the appropriate usage of Baxdela™ (delafloxacin). ​ … more

Encouraging results have been published re the company’s first Phase 3 PROCEED study, a multicenter, randomized, double-blind, active-controlled study that evaluated Baxdela™ compared with the combination regimen of vancomycin and aztreonam in 660 patients with ABSSSI (acute bacterial skin & skin structure infections)​ … more

A Phase 1 clinical study of topical radezolid for the treatment of mild-to-moderate acne vulgaris has been successfully completed. Results demonstrated that radezolid was well tolerated with minimal systemic absorption.​ … more